Cell and Tissue Research

, Volume 350, Issue 3, pp 401–407 | Cite as

Physical activity is linked to ceruloplasmin in the striatum of intact but not MPTP-treated primates

  • Rehana K. Leak
  • Krassimira A. Garbett
  • Amanda M. Dettmer
  • Zhiming Zhang
  • Károly Mirnics
  • Judy L. Cameron
Short Communication


Ceruloplasmin is a protective ferroxidase. Although some studies suggest that plasma ceruloplasmin levels are raised by exercise, the impact of exercise on brain ceruloplasmin is unknown. We have examined whether striatal ceruloplasmin is raised with treadmill exercise and/or is correlated with spontaneous physical activity in rhesus monkeys. Parkinson’s disease is characterized by a loss in ceruloplasmin and, similarly, Parkinson’s models lead to a loss in antioxidant defenses. Exercise might protect against Parkinson’s disease and is known to prevent antioxidant loss in experimental models. We have therefore examined whether treadmill exercise prevents ceruloplasmin loss in monkeys treated unilaterally with the dopaminergic neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). We found that exercise raised ceruloplasmin expression in the caudate and accumbens but not the putamen of intact monkeys. However, putamen ceruloplasmin was correlated with spontaneous activity in a home pen. MPTP alone did not cause unilateral loss of ceruloplasmin but blocked the impact of exercise on ceruloplasmin. Similarly, the correlation between putamen ceruloplasmin and activity was also lost with MPTP. MPTP elicited loss of tyrosine hydroxylase in the treated hemisphere; the remaining tyrosine hydroxylase was correlated with overall daily activity (spontaneous activity plus that induced by the treadmill). Thus, treadmill activity can raise ceruloplasmin but this impact and the link with spontaneous activity are both diminished in Parkinsonian primates. Furthermore, low overall physical activity predicts greater loss of dopaminergic phenotype in MPTP-treated primates. These data have implications for the maintenance of active lifestyles in both healthy and neurodegenerative conditions.


Parkinson’s disease Neurodegeneration Antioxidant Exercise MPTP Rhesus monkey (female) 


  1. Berg D, Gerlach M, Youdim MB, Double KL, Zecca L, Riederer P, Becker G (2001) Brain iron pathways and their relevance to Parkinson’s disease. J Neurochem 79:225–236PubMedCrossRefGoogle Scholar
  2. Bharucha KJ, Friedman JK, Vincent AS, Ross ED (2008) Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson’s disease. J Neurol 255:1957–1962PubMedCrossRefGoogle Scholar
  3. Boll MC, Alcaraz-Zubeldia M, Montes S, Rios C (2008) Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases. Neurochem Res 33:1717–1723PubMedCrossRefGoogle Scholar
  4. Ding F, Luan L, Ai Y, Walton A, Gerhardt GA, Gash DM, Grondin R, Zhang Z (2008) Development of a stable, early stage unilateral model of Parkinson’s disease in middle-aged rhesus monkeys. Exp Neurol 212:431–439PubMedCrossRefGoogle Scholar
  5. Groenewegen HJ, Wright CI, Beijer AVJ (1996) The nucleus accumbens: gateway for limbic structures to reach the motor system? Elsevier, AmsterdamGoogle Scholar
  6. Grondin R, Zhang Z, Ai Y, Ding F, Walton AA, Surgener SP, Gerhardt GA, Gash DM (2008) Intraputamenal infusion of exogenous neurturin protein restores motor and dopaminergic function in the globus pallidus of MPTP-lesioned rhesus monkeys. Cell Transplant 17:373–381PubMedGoogle Scholar
  7. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A (2007) Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 39:1423–1434PubMedCrossRefGoogle Scholar
  8. Hauber W (1998) Involvement of basal ganglia transmitter systems in movement initiation. Prog Neurobiol 56:507–540PubMedCrossRefGoogle Scholar
  9. Hineno A, Kaneko K, Yoshida K, Ikeda S (2011) Ceruloplasmin protects against rotenone-induced oxidative stress and neurotoxicity. Neurochem Res 36:2127–2135PubMedCrossRefGoogle Scholar
  10. Jan C, Pessiglione M, Tremblay L, Tande D, Hirsch EC, Francois C (2003) Quantitative analysis of dopaminergic loss in relation to functional territories in MPTP-treated monkeys. Eur J Neurosci 18:2082–2086PubMedCrossRefGoogle Scholar
  11. Kaneko K, Hineno A, Yoshida K, Ikeda S (2008) Increased vulnerability to rotenone-induced neurotoxicity in ceruloplasmin-deficient mice. Neurosci Lett 446:56–58PubMedCrossRefGoogle Scholar
  12. Kenyon CL, Basaraba RJ, Bohn AA (2011) Influence of endurance exercise on serum concentrations of iron and acute phase proteins in racing sled dogs. J Am Vet Med Assoc 239:1201–1210PubMedCrossRefGoogle Scholar
  13. Lau YS, Patki G, Das-Panja K, Le WD, Ahmad SO (2011) Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration. Eur J Neurosci 33:1264–1274PubMedCrossRefGoogle Scholar
  14. Le Bourdelles B, Horellou P, Le Caer JP, Denefle P, Latta M, Haavik J, Guibert B, Mayaux JF, Mallet J (1991) Phosphorylation of human recombinant tyrosine hydroxylase isoforms 1 and 2: an additional phosphorylated residue in isoform 2, generated through alternative splicing. J Biol Chem 266:17124–17130PubMedGoogle Scholar
  15. Leak RK, Liou AK, Zigmond MJ (2006) Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning. J Neurochem 99:1151–1163PubMedCrossRefGoogle Scholar
  16. Leak RK, Zigmond MJ, Liou AK (2008) Adaptation to chronic MG132 reduces oxidative toxicity by a CuZnSOD-dependent mechanism. J Neurochem 106:860–874PubMedCrossRefGoogle Scholar
  17. Leak RK, Castro SL, Jaumotte JD, Smith AD, Zigmond MJ (2010) Assaying multiple biochemical variables from the same tissue sample. J Neurosci Methods 191:234–238PubMedCrossRefGoogle Scholar
  18. Liesen H, Dufaux B, Hollmann W (1977) Modifications of serum glycoproteins the days following a prolonged physical exercise and the influence of physical training. Eur J Appl Physiol Occup Physiol 37:243–254PubMedCrossRefGoogle Scholar
  19. Loeffler DA, LeWitt PA, Juneau PL, Sima AA, Nguyen HU, DeMaggio AJ, Brickman CM, Brewer GJ, Dick RD, Troyer MD, Kanaley L (1996) Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res 738:265–274PubMedCrossRefGoogle Scholar
  20. Patel BN, David S (1997) A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem 272:20185–20190PubMedCrossRefGoogle Scholar
  21. Radak Z, Chung HY, Koltai E, Taylor AW, Goto S (2008) Exercise, oxidative stress and hormesis. Ageing Res Rev 7:34–42PubMedCrossRefGoogle Scholar
  22. Resina A, Gatteschi L, Rubenni MG, Giamberardino MA, Imreh F (1991) Comparison of some serum copper parameters in trained professional soccer players and control subjects. J Sports Med Phys Fitness 31:413–416PubMedGoogle Scholar
  23. Rhyu IJ, Bytheway JA, Kohler SJ, Lange H, Lee KJ, Boklewski J, McCormick K, Williams NI, Stanton GB, Greenough WT, Cameron JL (2010) Effects of aerobic exercise training on cognitive function and cortical vascularity in monkeys. Neuroscience 167:1239–1248PubMedCrossRefGoogle Scholar
  24. Sullivan EL, Cameron JL (2010) A rapidly occurring compensatory decrease in physical activity counteracts diet-induced weight loss in female monkeys. Am J Physiol Regul Integr Comp Physiol 298:R1068–R1074PubMedCrossRefGoogle Scholar
  25. Texel SJ, Xu X, Harris ZL (2008) Ceruloplasmin in neurodegenerative diseases. Biochem Soc Trans 36:1277–1281PubMedCrossRefGoogle Scholar
  26. Texel SJ, Zhang J, Camandola S, Unger EL, Taub DD, Koehler RC, Harris ZL, Mattson MP (2011) Ceruloplasmin deficiency reduces levels of iron and BDNF in the cortex and striatum of young mice and increases their vulnerability to stroke. PLoS One 6:e25077PubMedCrossRefGoogle Scholar
  27. Torsdottir G, Kristinsson J, Snaedal J, Sveinbjornsdottir S, Gudmundsson G, Hreidarsson S, Johannesson T (2010) Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: a short review. J Neurol Sci 299:51–54PubMedCrossRefGoogle Scholar
  28. Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A, Chen H (2010) Physical activities and future risk of Parkinson disease. Neurology 75:341–348PubMedCrossRefGoogle Scholar
  29. Zhang Y, Barres BA (2010) Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr Opin Neurobiol 20:588–594PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Rehana K. Leak
    • 1
    • 7
  • Krassimira A. Garbett
    • 2
    • 3
  • Amanda M. Dettmer
    • 4
  • Zhiming Zhang
    • 5
    • 6
  • Károly Mirnics
    • 2
    • 3
  • Judy L. Cameron
    • 4
  1. 1.Division of Pharmaceutical Sciences, Mylan School of PharmacyDuquesne UniversityPittsburghUSA
  2. 2.Department of PsychiatryVanderbilt UniversityNashvilleUSA
  3. 3.Vanderbilt Kennedy Center for Research on Human DevelopmentVanderbilt UniversityNashvilleUSA
  4. 4.Department of PsychiatryUniversity of PittsburghPittsburghUSA
  5. 5.Department of Anatomy & Neurobiology, College of MedicineUniversity of KentuckyLexingtonUSA
  6. 6.Morris K. Udall Parkinson’s Disease Research Center for Excellence, College of MedicineUniversity of KentuckyLexingtonUSA
  7. 7.Division of Pharmaceutical SciencesDuquesne UniversityPittsburghUSA

Personalised recommendations